SUPREME-HN A Retrospective Cohort Study of PD-L1 in Recurrent and Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ezra Cohen, M.D.
University of California San Diego Moores Cancer Center
Principal Investigator - Sara Pai, M.D., Ph.D.
Massachusetts General Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Leipzig, Saxony, Germany
- Research Site
Athens, Greece
- Research Site
Legnago (VR), Verona, Italy
- Research Site
Milan, Italy
- Research Site
Osaka, Osaka, Japan
- Research Site
Kōtoku, Tokyo-To, Japan
- Research Site
Seoul, South Korea
- Research Site
Barcelona, Spain
- Research Site
Seville, Spain
- Research Site
La Jolla, California, United States
- Research Site
Atlanta, Georgia, United States
- Research Site
Hyattsville, Maryland, United States
- Research Site
Boston, Massachusetts, United States
- Research Site
Charlotte, North Carolina, United States
- Research Site
Portland, Oregon, United States
- Research Site
Sioux Falls, South Dakota, United States
- Research Site
Nashville, Tennessee, United States
- Research Site
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Sept 2015
- Primary completion
- 14 Nov 2016
- Completion
- 14 Nov 2016
- Last update posted
- 14 Nov 2017
- Registered enrollment
- 412
- Registry id
- NCT02543476
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.